nad has been researched along with Chronic Kidney Diseases in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 12 (85.71) | 2.80 |
| Authors | Studies |
|---|---|
| Coleman, MD; Ryan, TE; Thome, T | 1 |
| Hasegawa, K; Higuchi, N; Ikeda, M; Itoh, H; Itoh, T; Kanda, T; Komatsu, M; Kuroita, T; Minakuchi, H; Ono, T; Shigaki, S; Takahashi, R; Tokuyama, H; Tsukamoto, T; Urai, H; Wakino, S; Yamanaka, R; Yoshimura, N; Yukioka, H | 1 |
| Desir, GV | 1 |
| Chanvillard, L; Sorrentino, V; Tammaro, A | 1 |
| Egstrand, S; Fang, EF; Gravesen, E; Hornum, M; Kanbay, M; Mace, ML; Morevati, M; Nordholm, A | 1 |
| Auwerx, J; Azhar, N; Bachmann, AM; Breyer, M; Broeckx, E; Carreira, V; Chen, T; Gonzalez-Villalobos, RA; Hofer, D; Li, TY; Ma, JY; Morel, JD; Mullican, S; Reilly, D; Sleiman, MB; von Alvensleben, G | 1 |
| Itoh, H; Kanda, T; Notoya, M; Ono, T; Takahashi, R; Wakino, S; Yamada, K; Yoshimura, N; Yukioka, H | 1 |
| Curran, CS; Kopp, JB | 1 |
| Parikh, SM; Ralto, KM; Rhee, EP | 1 |
| Chashmniam, S; Dalili, N; Kalantari, S; Nafar, M; Rezaie, D; Samavat, S | 1 |
| Harigae, H; Hashizume, Y; Ito, S; Kumakura, S; Miyazaki, M; Sato, E; Sekimoto, A; Takahashi, N; Yamakage, S | 1 |
| Andersen, CB; Egstrand, S; Lewin, E; Mace, ML; Morevati, M; Nordholm, A; Olgaard, K; Salmani, R | 1 |
| Brooks, HL; Coombes, JS; Gobe, GC; Johnson, DW; Morais, C; Roy, SF; Sanchez, WY; Small, DM | 1 |
| Desir, GV; Flavell, RA; Giordano, F; Li, G; Liu, D; Pestana, M; Quelhas-Santos, J; Russell, K; Russell, R; Sampaio-Maia, B; Velazquez, H; Wang, P; Wu, Y; Xu, J | 1 |
4 review(s) available for nad and Chronic Kidney Diseases
| Article | Year |
|---|---|
NAD
Topics: Aging, Premature; Humans; Kidney; NAD; Renal Dialysis; Renal Insufficiency, Chronic | 2022 |
Roles of NAD
Topics: Acute Kidney Injury; Energy Metabolism; Humans; NAD; Poly(ADP-ribose) Polymerases; Renal Insufficiency, Chronic; Sirtuins | 2022 |
The complexity of nicotinamide adenine dinucleotide (NAD), hypoxic, and aryl hydrocarbon receptor cell signaling in chronic kidney disease.
Topics: Basic Helix-Loop-Helix Transcription Factors; Humans; Hypoxia; Ischemia; NAD; Niacin; Receptors, Aryl Hydrocarbon; Renal Insufficiency, Chronic; Signal Transduction; Vascular Diseases | 2023 |
NAD
Topics: Acute Kidney Injury; Adenosine Triphosphate; Animals; Humans; Kidney Tubules; NAD; NADP; Oxidation-Reduction; Poly(ADP-ribose) Polymerases; Renal Insufficiency, Chronic; Reperfusion Injury; Sirtuins | 2020 |
10 other study(ies) available for nad and Chronic Kidney Diseases
| Article | Year |
|---|---|
Mitochondrial Bioenergetic and Proteomic Phenotyping Reveals Organ-Specific Consequences of Chronic Kidney Disease in Mice.
Topics: Adenine; Animals; Electron Transport; Energy Metabolism; Feeding Behavior; Hydrogen Peroxide; Kidney; Male; Membrane Potential, Mitochondrial; Mice, Inbred C57BL; Mitochondria; Mitochondrial Proteins; NAD; Organ Specificity; Oxidation-Reduction; Phenotype; Proteome; Proteomics; Renal Insufficiency, Chronic | 2021 |
The significance of NAD + metabolites and nicotinamide N-methyltransferase in chronic kidney disease.
Topics: Animals; Female; Fibrosis; Humans; Male; Methionine; Mice; NAD; Niacinamide; Nicotinamide N-Methyltransferase; Renal Insufficiency, Chronic; Ureteral Obstruction | 2022 |
RENALASE: DISCOVERY, BIOLOGY, AND THERAPEUTIC APPLICATIONS.
Topics: Cisplatin; Humans; Monoamine Oxidase; NAD; Renal Insufficiency, Chronic | 2022 |
Mitochondrial and NAD+ metabolism predict recovery from acute kidney injury in a diverse mouse population.
Topics: Acute Kidney Injury; Animals; Humans; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; NAD; Renal Insufficiency, Chronic | 2023 |
N-methyl-2-pyridone-5-carboxamide (N-Me-2PY) has potent anti-fibrotic and anti-inflammatory activity in a fibrotic kidney model: is it an old uremic toxin?
Topics: Animals; Anti-Inflammatory Agents; Fibrosis; Interleukin-6; Kidney; Mice; NAD; Proto-Oncogene Proteins c-akt; Renal Insufficiency, Chronic; Uremic Toxins; Ureteral Obstruction | 2023 |
A Noninvasive Urine Metabolome Panel as Potential Biomarkers for Diagnosis of T Cell-Mediated Renal Transplant Rejection.
Topics: Acute Disease; Adenosine Diphosphate; Adult; Biomarkers; Cholesterol Esters; Cross-Sectional Studies; Female; gamma-Aminobutyric Acid; Graft Rejection; Graft Survival; Hippurates; Humans; Kidney Transplantation; Male; Metabolome; Middle Aged; NAD; Niacin; Niacinamide; Proline; Renal Insufficiency, Chronic; ROC Curve; Spermidine; T-Lymphocytes | 2020 |
Nicotinamide Attenuates the Progression of Renal Failure in a Mouse Model of Adenine-Induced Chronic Kidney Disease.
Topics: Adenine; Animals; Citric Acid Cycle; Disease Models, Animal; Disease Progression; Energy Metabolism; Glycolysis; Kidney; Male; Metabolic Networks and Pathways; Metabolome; Mice; Mice, Inbred C57BL; NAD; Niacinamide; Renal Insufficiency; Renal Insufficiency, Chronic | 2021 |
Effect of NAD+ boosting on kidney ischemia-reperfusion injury.
Topics: Acute Kidney Injury; Animals; Autophagy; Disease Progression; Fibrosis; Glucuronidase; Kidney; Klotho Proteins; Male; Mitochondria; NAD; Niacinamide; Protective Agents; Pyridinium Compounds; Random Allocation; Rats; Rats, Wistar; Renal Insufficiency, Chronic; Reperfusion Injury; Signal Transduction; Sirtuin 1; Treatment Outcome | 2021 |
N-acetyl-cysteine increases cellular dysfunction in progressive chronic kidney damage after acute kidney injury by dampening endogenous antioxidant responses.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Antioxidants; Apoptosis; Cell Proliferation; Disease Models, Animal; Disease Progression; Energy Metabolism; Kidney; Male; Mice, Inbred C57BL; Microscopy, Fluorescence, Multiphoton; Mitochondria; NAD; Oxidative Stress; Phosphorylation; PPAR gamma; Renal Insufficiency, Chronic; Signal Transduction; Time Factors; Transforming Growth Factor beta1 | 2018 |
Renalase deficiency aggravates ischemic myocardial damage.
Topics: Animals; Base Sequence; Cardiotonic Agents; Disease Models, Animal; DNA Primers; Epinephrine; Female; Humans; Hypertension; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Monoamine Oxidase; Myocardial Ischemia; NAD; Norepinephrine; Recombinant Proteins; Renal Insufficiency, Chronic | 2011 |